Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, Synthesis and Antitumor Activity of FAK/PLK1 Dual Inhibitors with Quinazolinone as the Skeleton
Juan Sun, Ze‐Yu Fang, Yi‐Nuo Tao, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 4
Closed Access | Times Cited: 9

Showing 9 citing articles:

Flavonol Derivatives Containing a Quinazolinone Moiety: Design, Synthesis, and Antiviral Activity
Chenyu Gong, Kaini Meng, Zhiling Sun, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 2
Closed Access | Times Cited: 10
Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
Xiao Wang, Na Li, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116678-116678
Closed Access | Times Cited: 7
Molecular modeling aided design, synthesis and biological evaluation of quinazoline derivatives for the treatment of human cancer
Cai‐Shi Liu, Jin-Peng Tong, Zheng Fang, et al.
Molecular Diversity (2025)
Closed Access
Structure–Activity relationship (SAR) of 18β-glycyrrhetinic acid derivatives on their antitumor activity through the PPARγ receptor and caspase-3 pathway
Juan Sun, Qi Zheng, Yiheng Zhang, et al.
Journal of Saudi Chemical Society (2024) Vol. 28, Iss. 2, pp. 101815-101815
Open Access | Times Cited: 2
FAK inhibitors in cancer, a patent review – an update on progress
Ya‐Xi Ye, Yuyao Cao, Lisheng Xu, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 593-610
Closed Access | Times Cited: 2
Discovery of anticancer function of Febrifugine: Inhibition of cell proliferation, induction of apoptosis and suppression steroid synthesis in bladder cancer cells
Jingyuan Chen, Shuhao Fan, Jianhua Guo, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116878-116878
Closed Access | Times Cited: 1
Unveiling the Therapeutic Potential of Quinazolinone Derivatives in Cancer Treatment: A Comprehensive Exploration
Jasneet Kaur, Sukhmeet Kaur, Muskan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 32
Closed Access | Times Cited: 1
Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential
Yingnan Li, Yuming Zhang, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116913-116913
Closed Access | Times Cited: 1
Design, Synthesis, Antitumour Evaluation, and In Silico Studies of Pyrazolo-[1,5-c]quinazolinone Derivatives Targeting Potential Cyclin-Dependent Kinases
Danyang Zheng, Chenqi Yang, Xiaogang Li, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6606-6606
Open Access | Times Cited: 4
Page 1

Scroll to top